中国社区医师Issue(23)：16-17,2.DOI:10.3969/j.issn.1007-614x.2014.23.8
支气管动脉灌注结合静脉化疗序贯治疗中晚期肺癌临床疗效观察
Clinical curative effect observation of bronchial artery infusion combined with intravenous chemotherapy in the sequential treatment of middle to late stage lung cancer
摘要
Abstract
To explore and analyze the clinical effect of bronchial artery infusion combined with intravenous chemotherapy in the treatment of middle to late stage non-small cell lung cancer.Methods:35 cases with middle to late stage non-small cell lung cancer were selected from February 2009 to February 2013.They were given bronchial artery infusion gemzar(imported gemcitabine hydrochloride) and cisplatin at the first day.They were given intravenous chemotherapy gemzar.28 days were one cycle.All cases received at least 2 cycles of treatment,and the efficacy and adverse reactions were evaluated after 2 cycles.Results:In all cases,3 cases were complete remission;22 cases were partial remission;8 cases were stable;2 cases were progress.The total effective rate was 71.4%.The half year survival rate was 100%.The 1 year survival rate was 54.3%.The patients showed different degree of adverse reactions.Conclusion:Bronchial artery infusion combined with intravenous chemotherapy in the sequential treatment of middle to late stage non-small cell lung cancer has better curative effect.Its adverse reactions can be tolerated.It has high value in clinical application.关键词
支气管动脉灌注/非小细胞型肺癌/吉西他滨Key words
Bronchial artery infusion/Non-small cell lung cancer/Gemcitabine引用本文复制引用
龙林,向华,张智明,刘觉仕..支气管动脉灌注结合静脉化疗序贯治疗中晚期肺癌临床疗效观察[J].中国社区医师,2014,(23):16-17,2.
